• No results found

Combinations of type 1 diabetes, celiac disease and allergy - An immunological challenge

N/A
N/A
Protected

Academic year: 2021

Share "Combinations of type 1 diabetes, celiac disease and allergy - An immunological challenge "

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

LINKÖPING UNIVERSITY MEDICAL DISSERTATIONS

NO 1277

Combinations of type 1 diabetes, celiac disease and allergy - An immunological challenge

Anna Kivling

LINKÖPING 2011

LINKÖPING UNIVERSITY MEDICAL DISSERTATIONS

NO 1277

Combinations of type 1 diabetes, celiac disease and allergy - An immunological challenge

Anna Kivling

LINKÖPING 2011

LINKÖPING UNIVERSITY MEDICAL DISSERTATIONS

NO 1277

Combinations of type 1 diabetes, celiac disease and allergy - An immunological challenge

Anna Kivling

LINKÖPING 2011

Anna Ki vling C ombinations of type 1 diabet es , c eliac disease and aller gy -An immunological challeng e

References

Related documents

The CiPiS study demonstrates that children with screening-detected celiac disease have subclinical signs of disease consisting of systemically increased levels of

In both our early indicators and mortality studies, where we followed up patients with T1DM who developed or did not develop AD (thus with different study periods and in

Chantzichristos D, Persson A, Miftaraj M, Eliasson B, Svensson A-M & Johannsson G “Early clinical indicators of Addison’s disease in patients with type 1 diabetes mellitus: a

Th e aim of this study has been to estimate the risk of a third sibling being aff ected in CD sib-pair families, identify the chromosomal region containing susceptibility genes in CD

Th is thesis shows that the risk for third sibling and parents is, as expected, increased in sib-pair families, as the expected risk of being aff ected in polygenic diseases is

ISBN 978-91-7833-882-5 (PRINT) ISBN 978-91-7833-883-2 (PDF) http://hdl.handle.net/2077/63285 Printed by Stema Specialtryck AB, Borås. Congenital

The large retrospective cohort design study in paper IV, describing the prevalence, incidence and mortality in patients with CHD and DM over up to 87 years

Hero C, Rawshani A, Svensson A-M, Franzén S, Eliasson B, Eeg-Olofsson K, Gudbjörnsdottir S Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death